TRJ's Principal Activity is the development and manufacture of analytical and life sciences instruments and devices.
|Bid / Ask||-|
|Volume (4w avg)|
|vs Sector (1yr)||-|
|vs ASX 200 (1yr)||+60.18%|
|ASX Rank||494 of 2,295|
|NTA per share||$0.00|
TRJ is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.
Trajan Group Holdings Limited (TRJ) is a global developer and manufacturer of analytical science instruments, devices and solutions. Trajan has operations in Australia and across the United States (US), Europe and Asia. Trajan designs and manufactures a portfolio of precision consumable products and devices and solutions.
No incorporation details available.
DPS and Yield calculations use the Pay Date.
|No dividends paid.|
See Upcoming Dividends for all ASX companies.
|Mr Mark Andrew Licciardo||Joint Company Secretary||Jun 2021|
|Mr Alister John Hodges||Chief Financial Officer,Joint Company Secretary||Jun 2021|
|Mr John Anthony Eales||Non-Executive Chairman,Non-Executive Director||Mar 2021||
Mr John Anthony Eales
Non-Executive Chairman,Non-Executive Director
Mr Eales has started a 10 year international sporting career with the Australian rugby team from 1991, captaining the Wallabies from 1996 until 2001. John has served as an executive, adviser, director and investor in a number of listed and unlisted private organizations. John co founded the Mettle Group in 2003 - a corporate consultancy which was acquired by Chandler Macleod in 2007. John currently sits on the ASX boards of Magellan Financial Group and Flight Centre Travel Group. He also sits on the board of FUJIFILM Data Management Solutions Pty Ltd and Executive Health Solutions. He recently stepped down from his role as a Director of The Palladium Group and continues to serve as a consultant to Australian companies, including Westpac. John has been a regular columnist in both the Australian Financial Review and The Australian over the last 20 years and is the author of two books, Learning from Legends Sport and Learning from Legends Business. He is the Chair of the World Rugby Hall of Fame Selection Panel and on the Rugby Australia Bid Advisory Committee for the Rugby World Cup 2027. He is also the member of the Risk Committee of the TRJ.
|Ms Sara Elizabeth Watts||Non-Executive Director||Mar 2021||
Ms Sara Elizabeth Watts
Ms Watts is an experienced Non Executive Director with financial and operational experience of more than 20 years in a range of industries including technology, education, NFP and resources. Sara's previous executive positions include Chief Financial Officer of IBM Australia/New Zealand, Head of Internal Audit for IBM Asia Pacific and Vice Principal (Operations) at the University of Sydney. Sara is a Non Executive Director of Syrah Resources where she is Chair of the Audit and Risk Committee. Other current appointments include Trustee of the Australian Museum where she is Chair of the Audit and Risk Committee, Non Executive Director of Intrepica (trading as LiteracyPlanet) and Chair of the Audit and Risk Committee of the Independent Broad Based Anti Corruption Commission, Victoria (IBAC). She is also the Chairman of the Risk Committee of the TRJ.
|Mr Rohit Khanna||Non-Executive Director||Mar 2021||
Mr Rohit Khanna
Mr Khanna has nearly 40 years of experience in analytical science, business leadership and laboratory application software. In 1981, Rohit co founded Dynamic Solutions, a software engineering firm dedicated to providing computing solutions to the scientific and engineering community. The company was acquired by Waters Corporation in 1986. Rohit went on to hold various senior management roles at Waters Corporation, including Vice President and General Manager of the Data Products Group. In 2002, Rohit was appointed Vice President, Worldwide Marketing, and most recently Rohit was Senior Vice President of several Waters Corporation businesses including Informatics, Service, and Chemistry - along with being a member of the Corporate Executive Committee. Rohit retired from Waters Corporation at the end of 2017 but remains connected to the industry, participating on several Boards and providing strategic advisory services. He was also a National Science Foundation Fellow of California Institute of Technology. He is also the member of the Risk Committee of the TRJ.
|Ms Tiffiny Jane Lewin||Non-Executive Director||Mar 2021||
Ms Tiffiny Jane Lewin
Ms Lewin operational, risk and strategy experience gained over a 30 year career in the consumer goods, manufacturing, professional services and the finance sectors. Tiffiny is currently a senior leader at Westpac Group where she has served since 2015. She is the Director of Root Cause, and previously held roles as General Manager Premium Bank Victoria and Head of Customer Advocate Office. Prior to Westpac, Tiffiny held senior leadership, operational and strategy roles across Australia and Asia for global organizations including Nestle Australia, Nestle Japan, SCA Hygiene, Mondelez International and Procter & Gamble, where she managed organizational transformation, performance turnaround and market growth across business and consumer sectors. Previously, Tiffiny has acted as a board adviser to Trajan. She is also the member of the Risk Committee of the TRJ.
|Mr Robert (Bob) John Lyon||Head of Corporate Development and General Counsel,Executive Director||Sep 2014||
Mr Robert (Bob) John Lyon
Head of Corporate Development and General Counsel,Executive Director
Mr Lyon has global responsibility for the strategic growth of Trajan's business through mergers and acquisitions, licensing arrangements, and commercial relationships with Trajan's industry, academic, government and research partners in the scientific and medical sectors globally. Prior to joining Trajan, Robert had a 15 year career in law including as a partner at Page Seager Lawyers before spending six years with KPMG Corporate Finance.
|Mr Stephen Andrew Tomisich||Chief Executive Officer,Co-Founder,Managing Director||Aug 2011||
Mr Stephen Andrew Tomisich
Chief Executive Officer,Co-Founder,Managing Director
Mr Tomisich has entered in the analytical science industry in 1984 and has held several senior leadership roles in the industry, both in Australia and internationally. Immediately prior to co founding Trajan, Stephen was the Chief Executive Officer of SGE Analytical Science, a role he retained until Trajan acquired part of that business in 2013. Other industry roles include Managing Director of PerkinElmer Australia and Africa, Director of Marketing at Vision Systems (since acquired by Danaher), Managing Director of Selby Biolab and other senior roles at Varian Instruments (now Agilent Technologies) in both Australia and the US.
The current holdings of TRJ directors.
|Director||Last Notice||Direct Shares||Indirect Shares||Options||Convertibles|
|Robert (Bob) Lyon||03/09/2014||N/A||252,940||439,250||N/A|
No Substantial Shareholders for TRJ in our database.
12 month transaction history compiled from ASX announcements.
|Date||Name||Bought||Previous %||New %|
|07-06-21||Australiansuper Pty Ltd||8,341,177||--||6.44|
|07-06-21||Tomisich Family Pty Ltd||76,470,588||--||59.03|
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.